VEXT — Vext Science Balance Sheet
0.000.00%
- CA$30.93m
- CA$79.27m
- $36.00m
- 60
- 79
- 30
- 57
Annual balance sheet for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.75 | 6.47 | 5.93 | 8.72 | 4.62 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19.9 | 24.2 | 22.3 | 8.45 | 1.94 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 24 | 31.2 | 51.9 | 41.3 | 26.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 12.7 | 29 | 36.4 | 41.2 | 39.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 55.5 | 83.7 | 121 | 150 | 137 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.83 | 9.74 | 15.7 | 14 | 17.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 19.1 | 24.3 | 48.6 | 54.6 | 61.2 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 36.3 | 59.4 | 71.9 | 95 | 75.7 |
Total Liabilities & Shareholders' Equity | 55.5 | 83.7 | 121 | 150 | 137 |
Total Common Shares Outstanding |